FDA approves Incyte's Opzelura cream for children aged two and older with atopic dermatitis, expanding its use beyond teens ...

Incyte INCY announced that the FDA has approved the label expansion of Opzelura (ruxolitinib) cream 1.5%. Opzelura, a topical ...

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis ...

The US FDA has approved ruxolitinib (Opzelura) cream 1.5% for the short-term and noncontinuous chronic treatment of ...

Incyte (INCY) “announced that the FDA has approved Opzelura cream 1.5%, a topical Janus kinase inhibitor, for the short-term and non-continuous ...

Q: For almost two months now, I've had bumps on the back, sides and crown of my head. They itch all the time — and even more ...

For almost two months now, I've had bumps on the back, sides and crown of my head. They itch all the time-- and even more when I get hot. When I scratch, I see white or brown flakes.

Rosacea can cause redness, breakouts, and discomfort. Here, dermatologists share moisturizers that may help color-correct ...